Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by Aspertheoldmanon Apr 17, 2012 9:42pm
162 Views
Post# 19805438

Some answers to silly comments

Some answers to silly comments

 

"" Challenges/Risks for Automodular:

•100% of revenues come from Ford Motor Company. The business can be impacted adversely if Ford sales are down or contracts are not renewed;
•New labor contract signed by OEMs have reduced the differences in wages with Automodular. The smaller wage difference provides opportunities for OEMs to bring assemblies in-house;
•Continuous pressure from automotive companies to reduce costs can affect future profitability; and
•The Company is dependent on a small group of key personnel, the loss of any one of which could adversely affect operations. ""

Every annual report from every company includes the same kind of comment. It is an obligation.

Coke is risky because its sale comes mostly from selling Coke, Apple is risky because most ot its revenues comes from selling I-pPod and I-Pad, GM is risky because it's revenues come mostly from selling cars in a very competitive environement etc


     "" Why are you talking about Buffet? He seeks low risk investment that provide him a guaranteed return. He wouldn't touch AM with a 10 foot pole.  They have one major customer..ONE and that customer sells car during a time the US recovery is on shaky legs.   That is why it isn't moving above $3 anytime soon. ""

 Let me remind you that on feb 7th, AM reached $3.07 .

   "" You don't even have a clue how Buffet invests ""

If you are so familiar with Buffett, how come you did not know he has prostate cancer !!!

Bullboard Posts